PyInvesting

Market research

688016.SHG Shanghai MicroPort Endovascular MedTech Co., Ltd

SHG CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
10B
P/E ratio
17.8
Analyst target
127.25
Dividend yield
2.8%
Beta
0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Shanghai MicroPort Endovascular MedTech Co., Ltd is currently in a long term uptrend where the price is trading 34.7% above its 200 day moving average.

From a valuation standpoint, the stock is 362.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 44.5.

Shanghai MicroPort Endovascular MedTech Co., Ltd's total revenue rose by 64.9% to $142M since the same quarter in the previous year.

Its net income has increased by 78.7% to $52M since the same quarter in the previous year.

Finally, its free cash flow grew by 182.2% to $67M since the same quarter in the previous year.

Based on the above factors, Shanghai MicroPort Endovascular MedTech Co., Ltd gets an overall score of 4/5.